Summary
Four patients with a biliary fistula received 0.5 mg3H-methylproscillaridin as a single oral dose. 55% of the dose was excreted in bile, 16% in urine and 3% in faeces. More than 60% of the radioactivity excreted in bile and urine appeared within the first 24 hours. 78% of the radioactivity in bile consisted of CHCl3-insoluble metabolites of methylproscillaridin, incubation of which with β-glucuronidase led to splitting off glucuronic acid from almost 80%. Methylproscillaridin can be regarded as the principal conjugated compound. TLC-separation of CHCl3-soluble compounds from bile showed identical running of radioactivity with methylproscillaridin, proscillaridin and scillarenin and three unknown metabolites P1, P2, and P3. In urine the CHCl3-soluble fraction averaged 16% to 34% of the total amount and was identified as methylproscillaridin, proscillaridin, scillarenin, P2 and P3. The relative composition of the total radioactivity in faeces amounted to 77% methyl-proscillardidin, 4% scillarenin and 12% polar metabolites.
Similar content being viewed by others
References
Abshagen, U., Rennekamp, H., Küchler, R., Rietbrock, N.: Formation and disposition of bis and monoglycosides after administration of3H-4‴ — methyldigoxin to man. Europ. J. clin. Pharmacol.7, 177–181 (1974)
Belz, G.G., Belz, G., Schreiter, H.: Glykosidplasmaspiegel und Elektrokardiogramm nach einmaliger intravenöser und oraler Applikation von Methylproscillaridin bei gesunden Probanden. Verh. dtsch. Ges. inn. Med.80, 1080–1083 (1974a)
Belz, G.G., Nübling, H., Schmidt-Wiederkhr, P., Franz, H.E.: Plasmakonzentration und Elimination von Methylproscillaridin bei Niereninsuffizienz. Klin. Wschr.52, 1078–1081 1974b)
Greenberger, N.J., MacDermott, R.P., Martin, J.F., Dutta, S.: Intestinal absorption of six tritium labeled digitalis glycosides in rats and guinea pigs. J. Pharmacol. exp. Ther.167, 265–273 (1969)
Hawksworth, G., Drasar, B.S., Hill, M.J.: Intestinal bacteria and the hydrolysis of glycosidic bonds. J. med. Microbiol.4, 451–459 (1971)
Kuhlmann, J., Abshagen, U., Rietbrock, N.: Pharmacokinetics and metabolism of digoxigenin-mono-digitoxoside in man. Europ. J. clin. Pharmacol.7, 87–94 (1974)
Rietbrock, N., Abshagen, U., v.Bergmann, K., Kewitz, H.: Pharmacokinetics of digoxin and its 4‴ acetyl- and methylderivates in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol.274, 171–181 (1972)
Rietbrock, N., Staud, R.: Metabolism and excretion of methylproscillaridin by man. Europ. J. clin. Pharmacol.8, 427–432 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Staud, R., Rietbrock, N. & Fassbender, H.P. Excretion of methylproscillaridin in patients with a biliary fistula. Eur J Clin Pharmacol 9, 99–103 (1975). https://doi.org/10.1007/BF00614004
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00614004